Analgesics Market to reach USD 75.73 billion by 2032, developing at a CAGR of 5.39%
The global analgesics market is poised for growth, driven by the rising prevalence of chronic pain and the increasing need for effective pain management solutions. According to the Global Burden of Disease Study, chronic pain conditions such as lower back pain and arthritis affect over 1.5 billion people globally, underscoring the growing demand for analgesics. In the United States alone, the CDC reports that approximately 20.4% of adults experience chronic pain, with 8% suffering from high-impact chronic pain that significantly affects their quality of life.